Free tool
Stocks far below their 52-week high
We cover 10 companies trading at least 50% below their own 52-week high. The median market value in the group is $69.24M. Across the group, the median move over the past trading day is +0.48%. Price change over the past year runs from −66.3% to +104.5% across the middle 80 percent of the group, with a median of −32.7%.
Other lists in this group
Table
10 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | $381.80M | Small cap | −33.79% |
| YDES | YD Bio Ltd | $307.41M | Small cap | −63.83% |
| NGEN | NervGen Pharma Corp. | $223.65M | Small cap | −8.30% |
| SPRB | Spruce Biosciences, Inc. | $176.69M | Small cap | +721.93% |
| DWTX | Dogwood Therapeutics, Inc. | $90.42M | Micro cap | −42.80% |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% |
| FBLG | FibroBiologics, Inc. | $9.39M | Micro cap | −88.25% |
| XBIO | Xenetic Biosciences, Inc. | $9.04M | Micro cap | +35.92% |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.